Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?

Journal of Epidemiology and Community Health

Volumn 56, Issue SUPPL. 1, 2002, Pages

  Moons, K G M ^a   Bots, M L ^a,b   Salonen, J T ^c   Elwood, P C ^d   Freire de Concalves, A ^e   Nikitin, Y ^f   Sivenius, J ^c   Inzitari, D ^g   Benetou, V ^h   Tuomilehto, J ⁱ   Koudstaal, P J ^b   Grobbee, D E ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d LLANDOUGH HOSPITAL   (United Kingdom)

^e CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^f INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^g UNIVERSITY OF FLORENCE   (Italy)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; LIPID;

HEALTH RISK; METHODOLOGY; RISK FACTOR;

ADULT; AGED; ANAMNESIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; EUROPE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREDICTION; PULSE RATE; RISK ASSESSMENT; SCREENING TEST; SMOKING HABIT; STROKE;

EUROPE;

EID: 0036154130     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.56.suppl_1.i30     Document Type: Article

References (49)

1. Cholesterol lowering and mortality: The importance of considering the initial level of risk
2. Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension
3. West of Scotland Coronary Prevention study: Identification of highrisk groups and comparison with other cardiovascular intervention trials
4. Management guidelines in essential hypertension: Report of the second working party of the British Hypertension Society
5. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
6. Prevention of coronary heart disease in clinical practice; recommendation of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
7. An updated coronary risk profile. A statement for health professionals
8. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men
9. Probability of stroke: A risk profile from the Framingham study
10. We need stronger predictors of major vascular events in patients with a recent transient ischemic attack or nondisabling stroke
11. Comparison of probability of stroke between the Copenhagen City Heart study and the Framingham study
12. Cardiovascular risk and all cause mortality; a 12-year follow-up study in The Netherlands
13. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes
14. Measuring plasma fibrinogen to predict stroke and myocardial infarction
15. Fibrinogen as a risk factor for stroke and myocardial infarction
16. Femoral atherosclerosis in an older British population: Prevalence and risk factors
17. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
18. The treatment of coronary heart disease: An update. Part 1: An overview of the risk factors for cardiovascular disease
19. Prevalence, determinants, and misclassification of myocardial infarction in the elderly
20. Incidence and risk factors for ischaemic and haemorrhagic stroke in Europa. EUROSTROKE: A collaborative study among research centres in Europa: Rationale and design
21. Classification and natural history of clinically identifiable subtypes of cerebral infarction
22. Secondary prevention in non-rheumatic atrial fibrillation after transcient ischeamic attack or minor stroke
23. High density lipoprotein, HDL2 and HDL3 subfractions and the risk of acute myocardial infarction: A prospective population study in Eastern Finnish men
24. The FinMonica stroke register. Community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985
25. Determinants of disease and disability in the elderly. The Rotterdam Elderly study
26. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam study
27. Caerphilly and speedwell collaborative heart disease studies
28. Methodology for the modular electriocardiogram analysis system (MEANS)
29. The diagnostic performance of computer programs for the interpretation of electrocardiograms
30. Prevalence, determinants, and misclassification of myocardial infarction in the elderly
31. Regression models in clinical studies: Determining relationships between predictors and response
32. Multivarable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
33. The meaning and use of the area under a receiver operating characteristic (ROC) curve
34. Comparing the areas under two or more correlated receiver operating characteristic curves: A non parametric approach
35. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
36. Estimating the error of a prediction rule: Improvement on cross-validation
37. A critical look at methods for handling missing covariates in epidemiologic regression analysis
38. Regression with missing X's: A review
39. Proportion of disease caused or prevented by a given exposure, trait or intervention
40. The factor V Arg506Gln mutation is not associated with cardiovascular mortality in older women
41. Stroke incidence and risk factors for stroke in Copenhagen, Denmark
42. Smoking as a risk factor for cerebral ische-mia
43. Lifestyle factors and risk of cerebral infarction
44. Analysis of risk factors for stroke in a cohort of men born in 1913
45. The importance of disease prevalence in transporting clinical prediction rules
46. Transportability of a decision rule for the diagnosis of streptococcal pharyngitis